Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitors was written by Williams, David K.;Chen, Xiao-Tao;Tarby, Christine;Kaltenbach, Robert;Cai, Zhen-Wei;Tokarski, John S.;An, Yongmi;Sack, John S.;Wautlet, Barri;Gullo-Brown, Johnni;Henley, Benjamin J.;Jeyaseelan, Robert;Kellar, Kristen;Manne, Veeraswamy;Trainor, George L.;Lombardo, Louis J.;Fargnoli, Joseph;Borzilleri, Robert M.. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2010.Reference of 29241-66-5 This article mentions the following:
Aminopyridinyloxy- or azaindolyloxy phenylamino heteroarylcarboxamides such as I are prepared and tested for their inhibition of Met kinase and for their inhibition of a human gastric cancer cell line. X-ray crystallog. of an aminopyridinyloxyphenylamino pyridinecarboxamide bound to Met kinase reveals that these compounds adopt a bioactive conformation, in the kinase domain, consistent with that seen for a 2-pyridone-based Met kinase inhibitor. I demonstrated potent in vivo antitumor activity in the GTL-16 human tumor xenograft model; its selectivity against various kinases is determined In the experiment, the researchers used many compounds, for example, 5-Bromo-2-fluoronicotinic acid (cas: 29241-66-5Reference of 29241-66-5).
5-Bromo-2-fluoronicotinic acid (cas: 29241-66-5) belongs to organobromine compounds. Many of the organo bromine compounds are relatively nonpolar. Bromine is more electronegative than carbon (2.8 vs 2.5) and hence the carbon in a carbonbromine bond is electrophilic in nature. The principal reactions for organobromides include dehydrobromination, Grignard reactions, reductive coupling, and nucleophilic substitution.Reference of 29241-66-5
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary